ESSA Pharma (NASDAQ:EPIX) Share Price Crosses Below 50-Day Moving Average – Here’s What Happened

ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $5.93 and traded as low as $5.00. ESSA Pharma shares last traded at $5.37, with a volume of 89,307 shares traded.

ESSA Pharma Trading Down 6.4 %

The company has a market capitalization of $238.23 million, a PE ratio of -8.52 and a beta of 1.83. The business’s fifty day moving average is $5.93 and its two-hundred day moving average is $5.83.

ESSA Pharma (NASDAQ:EPIX) (TSE:EPI) last announced its quarterly earnings data on Monday, August 5th. The company reported ($0.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.10. As a group, equities research analysts anticipate that ESSA Pharma Inc. will post -0.71 EPS for the current year.

Institutional Investors Weigh In On ESSA Pharma

An institutional investor recently bought a new position in ESSA Pharma stock. EntryPoint Capital LLC bought a new position in ESSA Pharma Inc. (NASDAQ:EPIX) (TSE:EPI) in the first quarter, according to the company in its most recent disclosure with the SEC. The fund bought 4,420 shares of the company’s stock, valued at approximately $38,000. 75.12% of the stock is owned by hedge funds and other institutional investors.

ESSA Pharma Company Profile

ESSA Pharma Inc, a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company’s lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer.